NCT04979975: Evaluating Safety and Efficacy of Repeat Doses of UB-621in Adult Patients With Recurrent Genital Herpes
- State
- Not started
- Phase
- Phase 2
- People
- 200 planned
- Started
- Dec 2023
- Primary completion
- Dec 2025
- Arms
- UB-621 low-dose
- Results
- None posted
- 28 Jul 2021: Trial registered